Key result
Multipoint left ventricle pacing did not increase echocardiographic response to CRT at 6 months, but reduced mortality or hospitalization vs historical controls.
Why the study?
Up to 40% of heart failure patients do not respond to CRT, and multipoint left ventricle pacing has been suggested to increase the response rate.
Does early activation of multipoint left ventricle pacing (MPP) improve echocardiographic response rates and clinical outcomes in patients receiving cardiac resynchronization therapy compared to a historical control?
Cohort (n=105)
Open-label
Yes
Does early activation of multipoint left ventricle pacing (MPP) improve echocardiographic response rates and clinical outcomes in patients receiving cardiac resynchronization therapy compared to a historical control?
Early activation of multipoint pacing in CRT did not significantly increase echocardiographic response rates at 6 months but was associated with lower mortality or all-cause hospitalizations compared to a historical cohort.
Answers are grounded in this paper and cite their sources.
MPP yields similar CRT echo response rates; associated with fewer events vs historical controls but leaves open need for randomized confirmation.
BACKGROUND : Although cardiac resynchronization therapy (CRT) is beneficial in most heart failure patients, up to 40% do not respond to CRT. It has been suggested that multipoint left ventricle pacing (MPP) would increase the response rate. AIM : To assess the CRT response rate at 6 months in patients implanted with a CRT device with the MPP feature activated early after the implant. METHODS This was a multicentre, prospective, open-label and non-randomized study. The primary endpoint was response to biventricular pacing defined as >15% relative reduction in left ventricular end-systolic volume (LVESV) comparing echocardiography measurements performed at baseline and 6 months by a core laboratory. Among secondary endpoints the combined endpoint of mortality or all-cause hospitalizations was evaluated. Primary study endpoint and clinical outcomes were compared to a Quarto II control cohort. RESULTS: 105 patients were included. The response rate was 64.6% (97.5% lower confidence bound 53%). Mean relative reduction in LVESV was 25.3% and mean absolute increase in LVEF was 9.4%. The subjects with device programmed using anatomical approach had showed a trend toward higher responder rate than those using the electrical approach (72% vs. 61.1%, p= 0.32). Compared with Quarto II, the combined endpoint of mortality and or all-cause hospitalizations was lower in Quarto III (12.4% vs 25.4%, p=0.004). CONCLUSIONS : Early activation of MPP was not associated to an advantage increasing echocardiography responders to CRT at 6 months of follow up. Nevertheless, MPP was associated with better clinical outcomes in comparison to a historical control cohort. Patients programmed using widest pacing cathodes had a numerically higher responder rate.
No takes yet. Share an insight, caveat, or question.
Osca et al. (2022) conducted a cohort in Heart failure (n=105). Multipoint left ventricle pacing (MPP) vs. Quarto II historical control cohort was evaluated on Response to biventricular pacing (>15% relative reduction in left ventricular end-systolic volume). Multipoint left ventricle pacing did not increase echocardiographic response to CRT at 6 months, but reduced mortality or hospitalization vs historical controls.
Synapse has enriched 10 related papers. Consider them for comparative context: